Advanced Cell Technology, Inc. Share Price OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board
- ^USD	-

10/02/16	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/01/16	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/12/15	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/12/15	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
11/11/15	OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	BU

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	02/02/2015

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-1.59%	-3.35%	+64.49%	+98.69%	69.54B
ARGENX SE	-1.34%	-0.75%	+48.56%	+90.63%	64.97B
BIONTECH SE	-8.37%	-12.43%	+0.14%	-15.42%	25.64B
INSMED INCORPORATED	-2.35%	-5.75%	-12.17%	+448.29%	25.89B
WUXI BIOLOGICS (CAYMAN) INC.	+0.30%	-0.69%	+63.18%	+11.93%	26.51B
PHARMAESSENTIA CORPORATION	-0.96%	+10.36%	+278.86%	+438.78%	20.22B
GENMAB A/S	-0.51%	+0.23%	+33.71%	-18.02%	19.98B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.91%	-4.37%	+13.33%	+531.29%	15.69B
EXELIXIS, INC.	-1.47%	+0.68%	+43.67%	+145.49%	13.49B
Average	-2.02%	-1.93%	+59.31%	+192.41%	31.33B
Weighted average by Cap.	-1.93%	-1.50%	+57.15%	+152.82%